fda warning letters compounded semaglutide october 2025 Patient Safety Updates fda compounding semaglutide warning letters

Abounader R, Ranganathan S, Kim B, Nichols C, Laterra J

They monitor how their body reacts to different foods, adjust their protein intake based on how full they feel, and identify which side effects indicate they need to adjust their approach

Many user reports describe meaningful reductions in perceived recovery time, sometimes characterized as "cutting healing in half." Those claims are anecdotal rather than clinically validated, and outcomes vary by injury severity, age, sleep, nutrition, and rehab adherence

Most pharmaceutical semaglutide products like Ozempic and Wegovy avoid this confusion entirely by using pre-filled pens that deliver fixed doses